Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation - PubMed (original) (raw)
Comparative Study
. 2004 May;24(5):1121-31.
Affiliations
- PMID: 15067333
Comparative Study
Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation
Hala Gali-Muhtasib et al. Int J Oncol. 2004 May.
Abstract
We have recently shown that quinoxaline 1,4-dioxides (QdNOs) are potent hypoxia selective cytotoxins that modulate hypoxia inducible factor-1alpha (HIF-1alpha) expression. In this study, we evaluated the cytotoxicity, anti-angiogenic, and radiosensitization activities of the two quinoxaline 1,4-dioxides (QdNOs), BPQ and DCQ. Clonogenic survival, Matrigel, and radiosensitization assays were performed in vitro and in vivo using Lewis lung carcinoma (LLC) and EMT-6 mammary adenocarcinoma cells. Transcript and protein levels of HIF-1alpha and VEGF were determined using RT-PCR and Western blotting, respectively. DCQ showed cytotoxic effects under hypoxic conditions for both cell lines. Treatment with either drug inhibited HIF-1alpha and VEGF secretion, with DCQ being more potent than BPQ. DCQ also inhibited the formation of tube-like structures of ECV-304 endothelial cells in Matrigel by 60-80% and significantly reduced neoangiogenesis in vivo. When combined with radiation (200-1000 cGy), DCQ resulted in the death of 100% of LLC or EMT-6 cells. Using the C57BL/6 mouse model, combined treatment with DCQ and radiation delayed the growth of LLC tumors for 17 days and reduced mean tumor volume by 80% at day 20. However, BPQ combined with radiation did not induce significant tumor regression. Histological analyses revealed a significant increase in tissue necrosis in tumors treated by DCQ and radiation. These results indicate a potent anti-angiogenic and radiation modification effect of two quinoxaline dioxides. These findings should stimulate further research in other tumor models as these compounds could have potential clinical applications in cancer therapy.
Similar articles
- Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
Ferrario A, von Tiehl KF, Rucker N, Schwarz MA, Gill PS, Gomer CJ. Ferrario A, et al. Cancer Res. 2000 Aug 1;60(15):4066-9. Cancer Res. 2000. PMID: 10945611 - Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
Gorski DH, Beckett MA, Jaskowiak NT, Calvin DP, Mauceri HJ, Salloum RM, Seetharam S, Koons A, Hari DM, Kufe DW, Weichselbaum RR. Gorski DH, et al. Cancer Res. 1999 Jul 15;59(14):3374-8. Cancer Res. 1999. PMID: 10416597 - Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
Forooghian F, Das B. Forooghian F, et al. Am J Ophthalmol. 2007 Nov;144(5):761-8. doi: 10.1016/j.ajo.2007.07.022. Epub 2007 Sep 17. Am J Ophthalmol. 2007. PMID: 17869204 - Antitumor interaction of short course endostatin and ionizing radiation.
Greenberger JS. Greenberger JS. Cancer J. 2000 Sep-Oct;6(5):279-81. Cancer J. 2000. PMID: 11079164 Review. No abstract available. - [Biomodulation and radiotherapy].
Bourhis J, Lartigau E. Bourhis J, et al. Cancer Radiother. 2000 Nov;4 Suppl 1:128s-133s. Cancer Radiother. 2000. PMID: 11194950 Review. French.
Cited by
- Quinoxaline 1,4-Dioxides: Advances in Chemistry and Chemotherapeutic Drug Development.
Buravchenko GI, Shchekotikhin AE. Buravchenko GI, et al. Pharmaceuticals (Basel). 2023 Aug 17;16(8):1174. doi: 10.3390/ph16081174. Pharmaceuticals (Basel). 2023. PMID: 37631089 Free PMC article. Review. - Synthesis of 7-amino-6-halogeno-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: a way forward for targeting hypoxia and drug resistance of cancer cells.
Buravchenko GI, Scherbakov AM, Dezhenkova LG, Monzote L, Shchekotikhin AE. Buravchenko GI, et al. RSC Adv. 2021 Dec 3;11(61):38782-38795. doi: 10.1039/d1ra07978f. eCollection 2021 Nov 29. RSC Adv. 2021. PMID: 35493230 Free PMC article. - The photoprotective effects of 2-benzoyl-3-phenylquinoxaline 1,4-dioxide against UVB-induced damage in HaCaT cells.
Mouawad J, Saadeh F, Tabosh HA, Haddadin MJ, Gali-Muhtasib H. Mouawad J, et al. Med Oncol. 2016 Aug;33(8):86. doi: 10.1007/s12032-016-0802-4. Epub 2016 Jul 4. Med Oncol. 2016. PMID: 27377483 - The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway.
Ghattass K, El-Sitt S, Zibara K, Rayes S, Haddadin MJ, El-Sabban M, Gali-Muhtasib H. Ghattass K, et al. Mol Cancer. 2014 Jan 24;13:12. doi: 10.1186/1476-4598-13-12. Mol Cancer. 2014. PMID: 24461075 Free PMC article. - Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21.
El-Khatib M, Geara F, Haddadin MJ, Gali-Muhtasib H. El-Khatib M, et al. Radiat Oncol. 2010 Nov 15;5:107. doi: 10.1186/1748-717X-5-107. Radiat Oncol. 2010. PMID: 21078189 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources